FDA Approves Second Alzheimer’s Drug That Can Modestly Slow Disease ...Middle East

(WASHINGTON) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients in the early stages of the incurable, memory-destroying ailment. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by Alzheimer’s. It’s only the second drug that’s been convincingly shown to delay cognitive decline in patients, following last year’s approval of a similar drug from Japanese drugmaker Eisai. [time-brightcove not-tgx=”true”] The delay seen with both drugs amounts to a matter of months — about seven months, in the case of Lilly’s drug. Patients and their famili

Hence then, the article about fda approves second alzheimer s drug that can modestly slow disease was published today ( Tuesday 02/07/2024 - 10:22 PM ) and is available on Time ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Second Alzheimer’s Drug That Can Modestly Slow Disease )

Also on site :

• No injuries reported after partial building collapse in the Bronx, officials say
• OpenAI buys tiny health records startup Torch for, reportedly, $100M
• Meta-backed Hupo finds growth after pivot to AI sales coaching from mental wellness